Log in or Sign up for Free to view tailored content for your specialty!
Respiratory Infections News
IDWeek will be entirely virtual again because of COVID-19
IDWeek organizers announced that the 2021 meeting will be entirely virtual again because of the continued presence of COVID-19 and related restrictions.
Viral co-detection linked with longer duration of ventilation in critically ill infants
Identification of viral type and number may aid in predicting the duration of positive pressure ventilation in critically ill infants with bronchiolitis, according to results published in the Annals of the American Thoracic Society.
Log in or Sign up for Free to view tailored content for your specialty!
In revised estimate, AstraZeneca says vaccine’s efficacy is 76%
In a revised estimate, AstraZeneca said in a news release Thursday that its COVID-19 vaccine candidate demonstrated an overall efficacy of 76% against symptomatic disease in a phase 3 trial conducted mostly in the United States.
Q&A: How can physicians ease COVID-19-related stress in pregnant women?
Many pregnant women reported experiencing psychological stress stemming from the COVID-19 pandemic and subsequent shelter-in-place orders, according to research published in BMC Pregnancy and Childbirth.
National CLABSI rate increased significantly during pandemic
The rate of central line-associated bloodstream infections in acute care hospitals increased significantly during the pandemic, researchers reported in Infection Control & Hospital Epidemiology.
Influenza vaccination may lower risk for all-cause, CV death in patients with CVD
Among patients with CVD, influenza vaccination was associated with lower risk for all-cause and CV death and major adverse CV events compared with no vaccination, according to a meta-analysis.
Will SARS-CoV-2 variants impact the severity of MIS-C?
SARS-CoV-2 variants continue to emerge. One variant, B.1.1.7, was predicted to become the dominant SARS-CoV-2 virus in the United States by March.
Strongyloides hyperinfection and its association with COVID-19 treatment
Corticosteroids are an important treatment modality for a multitude of indications. Currently, dexamethasone is one of the only proven treatment options for patients suffering from COVID-19.
SARS-CoV-2 triggers similar inflammatory syndromes in children and adults
Last April, clinicians in London reported a cluster of eight children in 10 days who developed hyperinflammatory shock with multiorgan involvement, which they described in The Lancet as being similar to Kawasaki disease shock syndrome.
Hooked on ID with Trini A. Mathew, MD
I had veterinary virologists as parents. My dad studied and worked on rabies for his PhD, and my mother was a pioneer in India on buffalopox virus, which is very closely related to cowpox and smallpox, also earning her PhD.
-
Headline News
AAP releases first clinical guidance for prescribing opioids to children
September 30, 20242 min read -
Headline News
Oral methotrexate added to usual analgesia reduces pain, stiffness in knee osteoarthritis
September 30, 20242 min read -
Headline News
‘Future-proof’ your practice with these tips
September 27, 20242 min read
-
Headline News
AAP releases first clinical guidance for prescribing opioids to children
September 30, 20242 min read -
Headline News
Oral methotrexate added to usual analgesia reduces pain, stiffness in knee osteoarthritis
September 30, 20242 min read -
Headline News
‘Future-proof’ your practice with these tips
September 27, 20242 min read